tiprankstipranks
Trending News
More News >
Novartis announces Phase III PSMAddition trial met primary endpoint
PremiumThe FlyNovartis announces Phase III PSMAddition trial met primary endpoint
9d ago
Cautious Outlook on Novartis AG Amid Promising Pluvicto Trial Results and Market Uncertainties
Premium
Ratings
Cautious Outlook on Novartis AG Amid Promising Pluvicto Trial Results and Market Uncertainties
9d ago
Novartis AG: Hold Rating Amid Promising Trials and Competitive Challenges
Premium
Ratings
Novartis AG: Hold Rating Amid Promising Trials and Competitive Challenges
9d ago
CMS demands on drug pricing ‘extreme,’ ‘highly problematic,’ says Leerink
PremiumThe FlyCMS demands on drug pricing ‘extreme,’ ‘highly problematic,’ says Leerink
22d ago
Sector Spotlight: Trump executive order targets drug prices
Premium
The Fly
Sector Spotlight: Trump executive order targets drug prices
26d ago
U.S. biotech companies debate relocating trials outside U.S., Reuters reports
Premium
The Fly
U.S. biotech companies debate relocating trials outside U.S., Reuters reports
28d ago
Trump to sign executive order aimed at lowering drug prices
PremiumThe FlyTrump to sign executive order aimed at lowering drug prices
1M ago
Pharma imports to U.S. surged in March ahead of tariffs, Reuters says
Premium
The Fly
Pharma imports to U.S. surged in March ahead of tariffs, Reuters says
1M ago
Novartis price target raised to CHF 89 from CHF 86 at Berenberg
Premium
The Fly
Novartis price target raised to CHF 89 from CHF 86 at Berenberg
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100